These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 56038
1. [Current concepts in the treatment of Basedow's disease]. Jaffiol C, Baldet L. Sem Hop; ; 51(37-38):2265-7. PubMed ID: 56038 [No Abstract] [Full Text] [Related]
2. [Treatment of Basedow's disease]. Bürgi H. Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173 [No Abstract] [Full Text] [Related]
3. [Effect of radical treatment of Basedow's disease on the ocular symptoms]. Lederer J. Ann Endocrinol (Paris); 1974 May; 35(1):79-81. PubMed ID: 4138226 [No Abstract] [Full Text] [Related]
4. [Therapy of Basedow's disease]. Burger AG. Schweiz Rundsch Med Prax; 1988 Feb 16; 77(7):143-5. PubMed ID: 2451854 [No Abstract] [Full Text] [Related]
5. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease. Bojarska-Szmygin A, Janicki K, Pietura R, Janicka L. Ann Univ Mariae Curie Sklodowska Med; 2003 Feb 16; 58(1):248-53. PubMed ID: 15314994 [Abstract] [Full Text] [Related]
6. [The ocular risks of treatment of Basedow's disease (author's transl)]. Mornex R, Pousset G, Guinet P. Ann Endocrinol (Paris); 1974 Feb 16; 35(1):74-8. PubMed ID: 4138066 [No Abstract] [Full Text] [Related]
7. [Basedow's disease. Individual therapy of is great significance]. Hörmann R. MMW Fortschr Med; 2005 Sep 01; 147(35-36):47. PubMed ID: 16180573 [No Abstract] [Full Text] [Related]
8. [Basedow's disease]. Scheidegger K. Schweiz Rundsch Med Prax; 1993 Aug 10; 82(32):840-4. PubMed ID: 7690495 [Abstract] [Full Text] [Related]
9. [Basedow's disease]. Shizume K. Naika; 1971 Jun 10; 27(6):1156-8. PubMed ID: 4103929 [No Abstract] [Full Text] [Related]
10. [Present status of treatment of Basedow's disease (including exophthalmos)]. Tamai H. Nihon Naika Gakkai Zasshi; 1997 Jul 10; 86(7):1142-6. PubMed ID: 9379090 [No Abstract] [Full Text] [Related]
11. [Characteristic of Basedow's disease in aged and pregnancy and the therapy ]. Iino S. Nihon Naika Gakkai Zasshi; 1990 Jul 10; 79(7):881-5. PubMed ID: 1700044 [No Abstract] [Full Text] [Related]
13. [Hyperthyreosis in Basedow's disease]. Välimäki MJ. Duodecim; 1998 Jul 10; 114(5):447-54. PubMed ID: 11466937 [No Abstract] [Full Text] [Related]
14. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases]. Mitouze J, Jaffiol C, Baldet L, Ghachem M. Rev Fr Endocrinol Clin; 1972 Jul 10; 13(4):339-61. PubMed ID: 4122472 [No Abstract] [Full Text] [Related]
15. [Pregnancy and Basedow's disease]. Iino S, Watanabe T, Ban Y. Nihon Rinsho; 1971 May 10; 29(5):1360-5. PubMed ID: 4103638 [No Abstract] [Full Text] [Related]
16. [Basedow's disease in children]. Nakajima H, Niimi H. Nihon Rinsho; 1971 May 10; 29(5):1355-9. PubMed ID: 4103637 [No Abstract] [Full Text] [Related]
17. [Surgical treatment of Basedow's disease. Review of a series of 823 operations (author's transl)]. Blondeau P, Wolfeler L, Rene L. Ann Chir; 1978 Dec 10; 32(10):779-87. PubMed ID: 86322 [No Abstract] [Full Text] [Related]
18. [Basedow's disease: medical treatment]. Gnudi A. Minerva Endocrinol; 1987 Dec 10; 12(1):45-7. PubMed ID: 3587200 [No Abstract] [Full Text] [Related]
19. [Treatment of Basedow's disease by long-term administration of synthetic antithyroid drugs associated with small doses of I-131 prescribed without dosimetry. Apropos of 293 cases with a follow-up of 12 years]. Jaffiol C, Baldet L, Robin M, Papachristou C, Mirouze J, Lapinski H. Ann Endocrinol (Paris); 1974 Dec 10; 35(1):34-5. PubMed ID: 4138155 [No Abstract] [Full Text] [Related]
20. [Therapy of Basedow's disease]. Windeck R. Klin Wochenschr; 1990 Jun 19; 68(12):637-9. PubMed ID: 1695958 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]